Thermal Burns
4
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
NT
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
MediWoundNexoBrid
MediWoundNexoBrid
NeoMatrix TherapeuticscP12
Clinical Trials (3)
Total enrollment: 326 patients across 3 trials
A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns
Start: May 2015Est. completion: Aug 2020175 patients
Phase 3Completed
A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care
Start: May 2015Est. completion: Dec 2022145 patients
Phase 3Completed
A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns
Start: May 2025Est. completion: Nov 20266 patients
Phase 2Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 326 patients
3 companies competing in this space